Showing results (181-190 of 210) with videos related to
Sort By:
Pageof 21
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 3, 2006
Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patientsC Viscoli, A Cometta, W V Kern, et al.British Journal of Clinical Pharmacology|December 1, 1992
Trimethoprim, alone or in combination with sulphamethoxazole, decreases the renal excretion of zidovudine and its glucuronideJ Y Chatton, A Munafo, J P Chave, et al.Schweizerische Medizinische Wochenschrift|September 22, 1990
[HIV epidemic: a study among physicians in Vaud]G Meystre-Agustoni, G Van Melle, J P Chave, et al.Critical Care Medicine|July 1, 1992
A novel score for predicting the mortality of septic shock patientsJ D Baumgartner, C Büla, C Vaney, et al.The New England Journal of Medicine|November 11, 1982
Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coliE J Ziegler, J A McCutchan, J Fierer, et al.The American Journal of Gastroenterology|December 1, 1994
Gastric and duodenal bacterial colonization in HIV-infected patients without gastrointestinal symptomsJ P Chave, J Thorens, F Fröhlich, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14D Le Roy, F Di Padova, R Tees, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 22, 2002
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patientsM P Glauser, U Brennscheidt, O Cornely, et al.Genitourinary Medicine|April 1, 1996
Epidemiology of cryptosporidiosis among European AIDS patientsC Pedersen, S Danner, A Lazzarin, et al.Journal of Inflammation|January 1, 1995
Contribution of TNF/TNF receptor and of Fas ligand to toxicity in murine models of endotoxemia and bacterial peritonitisD Heumann, D Le Roy, G Zanetti, et al.Pageof 21